Prostate Cancer Patients With Metabolic Syndrome Showed Low Grade Gleason Score When Diagnosed on Biopsy

Dutasteride mesotherapy in women with metabolic syndrome accelerated hair loss after initial regrowth, while women without metabolic syndrome saw continuous regrowth. The user with mild insulin resistance is hesitant to try topical dutasteride and seeks experiences from others with insulin resistance.

Finasteride may affect prostate sensation and size, with some users reporting easier urination. Concerns exist about prostate shrinkage even at lower doses.

Finasteride can cause persistent side effects, including mental health issues, and it's important to consult a doctor before starting. Baseline tests for testosterone, DHT, estradiol, and semen analysis are recommended, and caution is advised for those with a history of depression, anxiety, or diabetes.

The user received hormone test results showing normal estradiol and testosterone levels, low SHBG, and normal free androgen index. They are considering starting finasteride but are concerned due to being slightly overweight.

Finasteride use and its potential side effects, including erectile dysfunction and post-finasteride syndrome (PFS), with discussions on lifestyle factors and the influence of anxiety. Some users argue that PFS is not well-documented, while others share personal experiences of adverse effects.

The conversation is about someone planning to start finasteride for hair loss and wanting to interpret pre-treatment blood panels to assess the risk of side effects like gynecomastia. They list various tests to measure hormone levels and other health indicators.